rs147920887
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_023009.7(MARCKSL1):c.466G>A(p.Ala156Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000182 in 1,612,504 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_023009.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000251 AC: 63AN: 250866Hom.: 1 AF XY: 0.000273 AC XY: 37AN XY: 135600
GnomAD4 exome AF: 0.000183 AC: 267AN: 1460210Hom.: 2 Cov.: 31 AF XY: 0.000200 AC XY: 145AN XY: 726388
GnomAD4 genome AF: 0.000177 AC: 27AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.466G>A (p.A156T) alteration is located in exon 2 (coding exon 2) of the MARCKSL1 gene. This alteration results from a G to A substitution at nucleotide position 466, causing the alanine (A) at amino acid position 156 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at